It was reported that the patient was admitted with right posterior cerebral artery (pca) cerebrovascular accident (cva) and discharged to inpatient rehab facility. over the course of the week, there was an uptrend in power consumption on ventricular assist device (vad) and increase in lactate dehydrogenase (ldh).The patient was deemed not a candidate for vad exchange after discussion with the medical team.The patient was started on 24 hour tissue plasminogen activator (tpa) which normalized vad power and ldh.About a month after, there was another rise in vad power and suspect of pump thrombus.Tpa therapy was declined by the patient and family.The patient was released home on hospice care.Couple days after the patient was growing more tired and weak and it was decided to discontinue pump support.The patient passed away and shortly after the vad was turned off.
|
Investigation of this event is pending and a supplemental report will be sent upon its completion.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|